07/29/2020 / By Mike Adams
YouTube has de-platformed Del Bigtree’s “The Highwire” channel today, following Del’s coverage of hydroxychloroquine, the low-cost, off-patent drug that an increasing number of doctors are advocating as a treatment and cure for COVID-19.
The Highwire is a wildly popular broadcast covering vaccines, health freedom, masks, the pandemic and much more. Del Bigtree has become a well known analyst and celebrity among people who honor health freedom and medical choice.
YouTube’s blacklisting of Del Bigtree is the latest act of malicious censorship by Google / YouTube to try to silence all speech that discusses alternatives to lockdowns, vaccines, masks and high-profit pharmaceuticals.
It’s now obvious that Google, Facebook, YouTube and Twitter are waging an all-out war against humanity and are actively trying to mass murder as many people as possible before they get stopped.
Just a few days ago, I interviewed Del Bigtree about censorship and techno-tyranny. This must-see interview explains a lot (see below).
The Highwire airs live each Thursday at 1pm central at TheHighwire.com, and each episode is posted on Brighteon the following day at the Highwire Brighteon channel:
Brighteon.com/channels/highwire
Del has informed Natural News that more episodes of The Highwire are being migrated to Brighteon right now.
Tagged Under: banned, Big Tech, CDC, Censored, Censorship, coronavirus, Del Bigtree, FDA, free speech, Glitch, Google, hydroxychloroquine, rigged, tech giants, Twisted, vaccine wars, vaccines, WHO, YouTube
COPYRIGHT © 2018 TECHGIANTS.NEWS
All content posted on this site is protected under Free Speech. TechGiants.news is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. TechGiants.news assumes no responsibility for the use or misuse of this material. All trademarks, registered trademarks and service marks mentioned on this site are the property of their respective owners.